Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    21870978 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Apixaban for the Secondary Prevention of Thromboembolism Among Patients With the AntiphosPholipid Syndrome
Conditions: Antiphospholipid Syndrome;   Thrombosis
Interventions: Drug: Apixaban;   Drug: Warfarin
2 Completed
Has Results
Genetic Response to Warfarin in Healthy Subjects
Condition: Healthy
Intervention: Drug: Warfarin
3 Completed
Has Results
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
Conditions: Atrial Fibrillation;   Atrial Flutter
Interventions: Drug: warfarin;   Drug: apixaban

Indicates status has not been verified in more than two years